Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procrit Q2W Dosing in Anemic HIV Patients
NCT00317902Phase 4Completed
- Sponsor
- Ortho Biotech Inc.
- Start
- Oct 2002
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 4, open-label, single-arm trial of epoetin alfa in anemia, sponsored by Ortho Biotech Inc. Primary endpoint: Quality of Life (MOS-HIV General Health Perception) at Week 24. Started Oct 2002; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00317902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317902.